Search
tPA/tPA inhibitor 1
Structure:
- subunits include:
- tissue-type plasminogen activator
- plasminogen activator inhibitor 1
Laboratory:
- tPA/tPA inhibitor 1 in plasma
General
molecular complex
Properties
SUBUNITS: tissue-type plasminogen activator
MOTIF: signal sequence {1-22}
fibronectin type I domain or F1 module {39-81}
MOTIF: cysteine residue {C41}
MODIFICATION: cysteine residue {C71}
annexin A2 binding {42-52}
cysteine residue {C69}
MODIFICATION: cysteine residue {C78}
cysteine residue {C71}
MODIFICATION: cysteine residue {C41}
cysteine residue {C78}
MODIFICATION: cysteine residue {C69}
EGF domain {82-120}
MOTIF: cysteine residue {C86}
MODIFICATION: cysteine residue {C97}
cysteine residue {C91}
MODIFICATION: cysteine residue {C108}
Thr glycosylation site {T96}
cysteine residue {C97}
MODIFICATION: cysteine residue {C86}
tyrosine residue {102}
cysteine residue {C108}
MODIFICATION: cysteine residue {C91}
cysteine residue {C110}
MODIFICATION: cysteine residue {C119}
cysteine residue {C119}
MODIFICATION: cysteine residue {C110}
Kringle 1 {127-208}
MOTIF: cysteine residue {C127}
MODIFICATION: cysteine residue {C208}
cysteine residue {C148}
MODIFICATION: cysteine residue {C190}
N-glycosylation site {N152}
cysteine residue {C179}
MODIFICATION: cysteine residue {C203}
cysteine residue {C190}
MODIFICATION: cysteine residue {C148}
cysteine residue {C203}
MODIFICATION: cysteine residue {C179}
cysteine residue {C208}
MODIFICATION: cysteine residue {C127}
Kringle 2 {215-296}
MOTIF: cysteine residue {C215}
MODIFICATION: cysteine residue {C296}
N-glycosylation site {N219}
cysteine residue {C236}
MODIFICATION: cysteine residue {C278}
asparagine residue {253}
cysteine residue {C267}
MODIFICATION: cysteine residue {C291}
cysteine residue {C278}
MODIFICATION: cysteine residue {C236}
cysteine residue {C291}
MODIFICATION: cysteine residue {C267}
cysteine residue {C296}
MODIFICATION: cysteine residue {C215}
cysteine residue {C299}
MODIFICATION: cysteine residue {C-INTERCHAIN}
S1 domain {311-561}
MOTIF: cysteine residue {C342}
MODIFICATION: cysteine residue {C358}
cysteine residue {C350}
MODIFICATION: cysteine residue {C419}
histidine residue {H357}
cysteine residue {C358}
MODIFICATION: cysteine residue {C342}
aspartate residue {D406}
cysteine residue {C419}
MODIFICATION: cysteine residue {C350}
cysteine residue {C444}
MODIFICATION: cysteine residue {C519}
lysine residue {464}
cysteine residue {C476}
MODIFICATION: cysteine residue {C492}
N-glycosylation site {N483}
cysteine residue {C492}
MODIFICATION: cysteine residue {C476}
cysteine residue {C509}
MODIFICATION: cysteine residue {C537}
aspartate residue {512}
serine residue {S513}
cysteine residue {C519}
MODIFICATION: cysteine residue {C444}
cysteine residue {C537}
MODIFICATION: cysteine residue {C509}
SECRETED-BY: endothelial cell
plasminogen activator inhibitor 1
INHIBITS: serine protease
MOTIF: signal sequence {1-23}
N-glycosylation site {N232}
N-glycosylation site {N288}
N-glycosylation site {N352}
peptide motif {369-370}
References
Loinc
Components
plasminogen activator inhibitor 1; PAI; PAI-1; endothelial plasminogen activator inhibitor; Serpin E1 (SERPINE1 PAI1 PLANH1)
tissue-type plasminogen activator; t-PA; t-plasminogen activator; tPA (PLAT)